BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20028513)

  • 21. Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark.
    Lynge E; Beau AB; von Euler-Chelpin M; Napolitano G; Njor S; Olsen AH; Schwartz W; Vejborg I
    Breast Cancer Res Treat; 2020 Dec; 184(3):891-899. PubMed ID: 32862304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.
    Gunsoy NB; Garcia-Closas M; Moss SM
    Breast Cancer Res; 2012 Nov; 14(6):R152. PubMed ID: 23194032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overdiagnosis among women attending a population-based mammography screening program.
    Falk RS; Hofvind S; Skaane P; Haldorsen T
    Int J Cancer; 2013 Aug; 133(3):705-12. PubMed ID: 23355313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer incidence after the start of mammography screening in Denmark.
    Olsen AH; Jensen A; Njor SH; Villadsen E; Schwartz W; Vejborg I; Lynge E
    Br J Cancer; 2003 Feb; 88(3):362-5. PubMed ID: 12569377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
    Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
    Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer mortality in organised mammography screening in Denmark: comparative study.
    Jørgensen KJ; Zahl PH; Gøtzsche PC
    BMJ; 2010 Mar; 340():c1241. PubMed ID: 20332505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
    Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
    Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interval cancers in the Dutch breast cancer screening programme.
    Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
    Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Overdiagnosis in mammography screening].
    Zahl PH; Maehlen J
    Tidsskr Nor Laegeforen; 2004 Sep; 124(17):2238-9. PubMed ID: 15356688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.
    Heinävaara S; Sarkeala T; Anttila A
    Br J Cancer; 2014 Sep; 111(7):1463-8. PubMed ID: 25121953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interval breast cancers in a community screening programme: frequency, radiological classification and prognostic factors.
    Baré M; Sentís M; Galceran J; Ameijide A; Andreu X; Ganau S; Tortajada L; Planas J;
    Eur J Cancer Prev; 2008 Oct; 17(5):414-21. PubMed ID: 18714182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    Welch HG; Prorok PC; O'Malley AJ; Kramer BS
    N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age.
    Evans WP; Starr AL; Bennos ES
    Radiology; 1997 Aug; 204(2):489-91. PubMed ID: 9240541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
    Richman IB; Long JB; Soulos PR; Wang SY; Gross CP
    Ann Intern Med; 2023 Sep; 176(9):1172-1180. PubMed ID: 37549389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overdiagnosis of breast cancer after 14 years of mammography screening.
    Zahl PH; Mæhlen J
    Tidsskr Nor Laegeforen; 2012 Feb; 132(4):414-7. PubMed ID: 22353833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].
    Gocko X; Leclerq M; Plotton C
    Rev Epidemiol Sante Publique; 2018 Nov; 66(6):395-403. PubMed ID: 30316554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer incidence and overdiagnosis in Catalonia (Spain).
    Martinez-Alonso M; Vilaprinyo E; Marcos-Gragera R; Rue M
    Breast Cancer Res; 2010; 12(4):R58. PubMed ID: 20682042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term relationships between screening rates, breast cancer characteristics, and overdiagnosis in US counties, 1975-2009.
    Harding C; Pompei F; Burmistrov D; Wilson R
    Int J Cancer; 2019 Feb; 144(3):476-488. PubMed ID: 30264887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.